Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Simulations Plus ( (SLP) ) has shared an update.
On February 12, 2026, Simulations Plus, Inc. held its 2026 Annual Meeting of Shareholders in a virtual format, with about 66% of eligible shares represented. Shareholders elected four directors – Daniel Weiner, Walter S. Woltosz, John K. Paglia, and Sharlene Evans – to serve until the next annual meeting, reinforcing continuity in the company’s board leadership.
Investors also ratified Rose, Snyder & Jacobs LLP as the independent auditor for the fiscal year ending August 31, 2026, supporting stability in the company’s financial oversight. They approved an increase in shares available under the 2021 equity plan from 2,500,000 to 3,450,000, and backed holding say-on-pay votes on executive compensation every year, signaling support for ongoing equity-based incentives and regular governance feedback.
The most recent analyst rating on (SLP) stock is a Sell with a $12.00 price target. To see the full list of analyst forecasts on Simulations Plus stock, see the SLP Stock Forecast page.
Spark’s Take on SLP Stock
According to Spark, TipRanks’ AI Analyst, SLP is a Neutral.
Overall score reflects a conflicted setup: severe TTM revenue/profitability deterioration and strongly bearish technicals weigh heavily, partially offset by a very low-debt balance sheet, solid free cash flow, and reaffirmed FY2026 guidance pointing to stable operations with backlog-driven support.
To see Spark’s full report on SLP stock, click here.
More about Simulations Plus
Simulations Plus, Inc. operates in the software and technology sector, providing modeling and simulation tools for pharmaceutical and biotechnology research and development. The company focuses on in silico solutions that help drug developers predict safety, efficacy, and dosing, positioning it as a specialized provider in the life sciences and healthcare markets.
Average Trading Volume: 389,329
Technical Sentiment Signal: Sell
Current Market Cap: $247.6M
See more insights into SLP stock on TipRanks’ Stock Analysis page.